Can-Fite BioPharma Ltd. (TLV:CANF)
Israel
· Delayed Price · Currency is ILS · Price in ILA 752.50
-9.50 (-1.25%)
Mar 6, 2026, 1:44 PM IDT
Can-Fite BioPharma Employees
Can-Fite BioPharma had 5 employees as of December 31, 2024. The number of employees decreased by 3 or -37.50% compared to the previous year.
Employees
5
Change (1Y)
-3
Growth (1Y)
-37.50%
Revenue / Employee
377.36K ILS
Profits / Employee
-5.93M ILS
Market Cap
19.70M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| XTL Biopharmaceuticals | 10 |
| Purple Biotech | 9 |
| Evogene | 117 |
| BioLight Life Sciences | 4 |
| BioLineRx | 28 |
| Matricelf | 12 |
| Bonus BioGroup | 37 |
Can-Fite BioPharma News
- 3 days ago - Can-Fite's Namodenoson Hits Phase 2a Goal; Raises $4M Via Warrants - Nasdaq
- 3 days ago - Micro-Cap Can-Fite BioPharma Shares Surge On Successful Pancreatic Cancer Drug Study - Benzinga
- 3 days ago - Micro-Cap Can-Fite BioPharma Shares Surge On Successful Pancreatic Cancer Drug Study - Benzinga
- 3 days ago - Can-Fite BioPharma (CANF) Achieves Positive Results in Pancreatic Cancer Study - GuruFocus
- 3 days ago - Can-Fite's Namodenoson Successfully Meets Primary Endpoint in Phase 2a Pancreatic Cancer Study - GlobeNewsWire
- 18 days ago - Can-Fite BioPharma (CANF) Unveils Promising Obesity Study Results - GuruFocus
- 26 days ago - Can-Fite (CANF) Gains Canadian Patent for Anti-Obesity Drug Namodenoson - GuruFocus
- 4 weeks ago - Can-Fite BioPharma (CANF) Treatment Aids Successful Liver Transplant - GuruFocus